Cancer does not develop overnight. It can take decades for cancer‐promoting changes in the genome to eventually lead to the ...

Recent developments in protein-protein interactions (PPI) give hope for patients with advanced or untreatable diseases.

LONDON – Oncogene Cancer Research is proud to announce a £10,425 donation to The Institute of Cancer Research, London (ICR), raised through the efforts of three dedicated runners who took part in this ...

Chemotherapy can increase mutation burden and change the cell population structure of normal blood, which contributes to long-term adverse effects such as second malignancies and infertility, ...

The gene-editing platform known as Crispr is widely used by researchers in scientific laboratories in their search for new ...

Presented updated data for bexobrutideg (NX-5948) at EHA2025 and ICML-18, demonstrating a favorable safety profile and deepening responses in patients with r/r chronic lymphocytic leukemia (CLL) and ...

The securities described above are being offered pursuant to an automatic shelf registration statement on Form S-3ASR (File No. 333-269707), which was filed with the Securities and Exchange Commission ...

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that it has commenced an underwritten ...

Presented updated data for bexobrutideg (NX-5948) at EHA2025 and ICML-18, demonstrating a favorable safety profile and deepening responses in patients with r/r chronic lymphocytic leukemia (CLL) and ...

Cancer cells possess a remarkable quality called plasticity. This means they can change their form. This ability helps them survive and spread. Cancer cells act like young cells. They can adapt to ...